Microbial Etiology of Ventilator-associated Pneumonia in COVID-19 Infected Patients

Microbial Etiology of Ventilator-associated Pneumonia (VAP) in COVID-19 Infected Patients

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04344509

Enrollment

10000

Registered

2020-04-14

Start date

2020-06-30

Completion date

2020-12-31

Last updated

2020-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ventilator Associated Pneumonia

Brief summary

National multicentric observational retrospective case-control study comparing the relative frequency of the various microorganisms responsible for VAP in patients infected or not by SARS-CoV-2 and their resistance to antibiotics.

Interventions

OTHERBacterial species isolated

in the respiratory specimen

Study design

Observational model

CASE_CONTROL

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 100 Years

Healthy volunteers

Inclusion criteria

* All patients with microbiologically confirmed VAP with pulmonary samples collected from March 15 to April 15 in France.

Exclusion criteria

* All patients with microbiologically confirmed VAP with pulmonary samples collected from March 15 to April 15 in France.

Design outcomes

Primary

Measure	Time frame
Prevalence of the microorganisms responsible for VAP among patients infected or not by the SARS-CoV-2	1 month

Secondary

Measure	Time frame
Prevalence of multi-drug resistant bacteria responsible for VAP among patients infected or not by the SARS-CoV-2	1 month

Contacts

Primary ContactChristophe BURUCOA

christophe.burucoa@chu-poitiers.fr549443889

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026